Estados financieros detallados de Black Diamond Therapeutics, Inc. (BDTX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $1.94, BDTX presenta beneficios negativos (P/E no significativo) y un ROE del -38.80%. La capitalización bursátil es de $111M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $70.0M |
| Coste de Ventas | $24000 | $44000 | $47000 | 0 | 0 | 0 | $437000 | 0 | $325000 |
| Beneficio Bruto | -$24000 | -$44000 | -$47000 | 0 | 0 | 0 | -$437000 | 0 | $69.7M |
| I+D | $3.5M | $7.0M | $21.8M | $48.2M | $96.8M | $64.4M | $58.9M | $51.3M | $33.6M |
| Generales y Administrativos | $666000 | $2.0M | $7.6M | $21.4M | $30.0M | $28.4M | $27.1M | $27.5M | $16.6M |
| Gastos Operativos | $4.1M | $8.9M | $29.3M | $69.6M | $126.9M | $92.8M | $86.0M | $78.8M | $49.8M |
| Beneficio Operativo | -$4.1M | -$8.9M | -$8.9M | -$69.6M | -$126.9M | -$92.8M | -$86.5M | -$78.8M | $19.9M |
| EBITDA | -$4.1M | -$8.9M | -$29.3M | -$66.7M | -$125.4M | -$90.7M | -$82.0M | -$69.3M | $22.7M |
| Gastos por Intereses | $65000 | 0 | 0 | $1000 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$4.6M | -$8.9M | -$35.3M | -$67.3M | -$125.6M | -$91.2M | -$82.4M | -$69.7M | $22.4M |
| Impuestos | 0 | -$27000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$4.6M | -$8.9M | -$35.3M | -$67.3M | -$125.6M | -$91.2M | -$82.4M | -$69.7M | $22.4M |
| BPA | $-0.64 | $-0.64 | $-1.15 | $-2.04 | $-3.47 | $-2.52 | $-1.88 | $-1.27 | $0.39 |
| BPA Diluido | $-0.64 | $-0.64 | $-1.15 | $-2.04 | $-3.47 | $-2.52 | $-1.88 | $-1.27 | $0.39 |
| Acciones en Circulación (Diluidas) | $7.2M | $14.0M | $35.9M | $32.9M | $36.2M | $36.2M | $44.0M | $55.0M | $57.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | -$27000 | 0 |
| Beneficio Operativo | -$11.0M | -$17.6M | -$11.3M | -$12.1M |
| EBITDA | -$8.4M | -$10.2M | -$9.0M | -$13.3M |
| Beneficio Neto | -$8.5M | -$15.1M | -$9.0M | -$9.9M |
| BPA | $-0.15 | $-0.26 | $-0.16 | $-0.17 |
| BPA Diluido | $-0.15 | $-0.26 | $-0.16 | $-0.17 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $7.9M | $51.7M | $154.7M | $34.6M | $65.8M | $34.3M | $56.2M | $36.4M | $21.0M |
| Inversiones a Corto | 0 | 0 | 0 | $280.5M | $144.0M | $88.5M | $75.2M | $62.1M | $107.7M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $7.9M | $51.7M | $155.7M | $319.6M | $215.7M | $127.7M | $134.0M | $101.2M | $132.4M |
| Inmovilizado Material | $102000 | $134000 | $164000 | $8.8M | $30.7M | $27.4M | $23.7M | $20.4M | $9.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $8.0M | $51.8M | $158.3M | $329.7M | $247.7M | $156.3M | $158.6M | $122.6M | $143.0M |
| Cuentas por Pagar | $152000 | $416000 | $2.0M | $2.5M | $4.1M | $1.9M | $2.3M | $4.0M | $579000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.2M | $2.6M | $4.9M | $14.2M | $23.6M | $15.3M | $19.6M | $20.6M | $15.7M |
| Deuda a Largo | 0 | $60.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $14.7M | $67.4M | $205.5M | $21.9M | $51.8M | $40.6M | $41.8M | $39.4M | $30.8M |
| Reservas | -$6.8M | -$15.7M | -$51.0M | -$118.2M | -$243.8M | -$335.0M | -$417.4M | -$487.1M | -$464.7M |
| Patrimonio Neto | -$6.7M | -$15.5M | -$47.2M | $307.8M | $195.9M | $115.7M | $116.7M | $83.3M | $112.2M |
| Deuda Total | $12.5M | $60.8M | 0 | $8.7M | $28.5M | $28.1M | $25.3M | $22.2M | $18.8M |
| Deuda Neta | $4.6M | $9.1M | -$154.7M | -$306.3M | -$181.3M | -$94.7M | -$106.1M | -$76.4M | -$109.9M |
| Capital Circulante | $5.7M | $49.1M | $150.9M | $305.3M | $192.1M | $112.4M | $114.4M | $80.6M | $116.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $30.9M | $21.0M | $30.1M | $19.2M |
| Activos Totales | $157.7M | $143.0M | $132.9M | $125.0M |
| Pasivos Totales | $31.6M | $30.8M | $28.6M | $28.9M |
| Patrimonio Neto | $126.2M | $112.2M | $104.3M | $96.1M |
| Deuda Total | $19.7M | $18.8M | $17.9M | $17.0M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$4.6M | -$8.9M | -$35.3M | -$67.3M | -$125.6M | -$91.2M | -$82.4M | -$69.7M | $22.4M |
| Amortizaciones | $24000 | $44000 | $47000 | $52000 | $205000 | $508000 | $437000 | $343000 | $325000 |
| Compensación en Acciones | $5000 | $64000 | $3.6M | $7.8M | $14.0M | $12.2M | $9.6M | $10.6M | $6.6M |
| Cambio en Capital Circulante | $1.7M | $354000 | $463000 | $5.0M | $7.0M | -$9.9M | $3.7M | -$2.7M | -$8.7M |
| Flujo de Caja Operativo | -$2.4M | -$8.5M | -$24.7M | -$52.1M | -$100.1M | -$85.1M | -$66.7M | -$62.3M | $29.6M |
| Inversiones (CapEx) | -$77000 | -$76000 | -$21000 | -$142000 | -$2.7M | -$192000 | -$33000 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | $118000 | $2.7M | $9000 | 0 | $94000 | $27000 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$2.4M | -$8.5M | -$24.7M | -$52.3M | -$102.9M | -$85.3M | -$66.8M | -$62.3M | $29.6M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$7.8M | -$6.8M | -$10.2M | -$7.1M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$7.8M | -$6.8M | -$10.2M | -$7.1M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.7M | $1.4M | $1.4M | $1.5M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -94.1% | -294.8% | -90.7% | -86.7% | +27.4% | +9.6% | +15.5% | +132.1% |
| Crecimiento BPA (anual) | | +0.0% | -79.7% | -77.4% | -70.1% | +27.4% | +25.4% | +32.4% | +130.7% |
| Cambio en Acciones (anual) | | +93.9% | +157.4% | -8.4% | +10.0% | +0.1% | +21.3% | +25.2% | +4.6% |
| Crecimiento FCF (anual) | | -251.3% | -189.5% | -111.7% | -96.7% | +17.1% | +21.7% | +6.7% | +147.5% |
| Margen Bruto | | | | | | | | | 99.5% |
| Margen Operativo | | | | | | | | | 28.4% |
| Margen EBITDA | | | | | | | | | 32.4% |
| Margen Neto | | | | | | | | | 32.0% |
| Margen FCF | | | | | | | | | 42.3% |
| Tasa Impositiva Efectiva | -0.0% | 0.3% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.34 | $-0.61 | $-0.69 | $-1.59 | $-2.84 | $-2.35 | $-1.52 | $-1.13 | $0.51 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $7.2M | $14.0M | $35.9M | $32.9M | $36.2M | $36.2M | $44.0M | $55.0M | $56.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -38.80% |
| Rentabilidad sobre capital invertido | -45.91% |
| Rentabilidad sobre activos | -34.04% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.18 |
| Ratio corriente | 7.28 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -61.69 | -61.69 | -34.33 | -15.71 | -1.54 | -0.71 | -1.49 | -1.69 | 6.23 |
| P/VC | -42.56 | -35.44 | -30.06 | 3.43 | 0.98 | 0.56 | 1.06 | 1.41 | 1.23 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.97 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 99.5% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 28.4% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 32.0% |